Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Safety Study of a Partially Hydrolyzed Rice Protein Formula in Healthy Infants

NCT00997971 is registered in ClinicalTrials.gov with Sodilac as lead sponsor.

NCT NCT00997971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00997971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Safety Study of a Partially Hydrolyzed Rice Protein Formula in Healthy Infants
Lead sponsor
Sodilac
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2007
Completion date
August 31, 2009
Enrollment
86 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

allergy, growth